Thank you to our speakers, sponsors, and delegates who joined us in Boston for the summit! If you are interested in the 2026 event, please get in touch at info@hansonwade.com.
Explore the 2025 Event Guide to Discover
18 expert speakers from pioneering biotech and pharma companies, including Bristol Myers Squibb, Monument Therapeutics, Click Therapeutics, and 4M Therapeutics.Â
Two full days of content, plus pre-conference workshops tackling translational models, patient stratification, and clinical trial optimization.Â
Breakthrough sessions on muscarinic agonists, KCC2 activators, NMDA-targeting therapies, and digital biomarkers.Â
Exclusive investor and regulatory panels, tackling funding, clinical trial strategy, and commercialization in psychosis drug development.Â
Interactive roundtables, networking, and a scientific poster session connecting industry leaders to shape the future of psychosis therapeutics.Â
Download the 2025 Event Guide:
Having trouble downloading the brochure?
Let us know and we'll email it to you instead
Companies On The 2025 Program:
